Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) Interest & Investment Income (2019 - 2025)

Historic Interest & Investment Income for Eton Pharmaceuticals (ETON) over the last 4 years, with Q3 2025 value amounting to -$592000.0.

  • Eton Pharmaceuticals' Interest & Investment Income fell 730000.0% to -$592000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.7 million, marking a year-over-year decrease of 251960.78%. This contributed to the annual value of $281000.0 for FY2019, which is 7134.15% up from last year.
  • Latest data reveals that Eton Pharmaceuticals reported Interest & Investment Income of -$592000.0 as of Q3 2025, which was down 730000.0% from -$1.0 million recorded in Q2 2025.
  • Eton Pharmaceuticals' 5-year Interest & Investment Income high stood at -$8000.0 for Q3 2024, and its period low was -$1.0 million during Q2 2025.
  • Moreover, its 3-year median value for Interest & Investment Income was -$124000.0 (2023), whereas its average is -$335111.1.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first soared by 9126.98% in 2024, then tumbled by 924545.45% in 2025.
  • Eton Pharmaceuticals' Interest & Investment Income (Quarter) stood at -$31000.0 in 2023, then soared by 74.19% to -$8000.0 in 2024, then tumbled by 7300.0% to -$592000.0 in 2025.
  • Its Interest & Investment Income stands at -$592000.0 for Q3 2025, versus -$1.0 million for Q2 2025 and -$1.0 million for Q1 2025.